Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€61.80
08.03.21
-
08.03.22
-21.91%
09.03.22

DirectorDealer 
08.03.21 50%
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€61.80
08.03.21
-
08.03.22
-26.29%
09.03.22

DirectorDealer 
08.03.21 50%
buy
Bayer AG ADR

Start price
Target price
Perf. (%)
€13.10
08.03.21
€14.00
3.05%
10.03.21

EBIT growth >5% per year expected
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Traumtanz 
08.03.21 60%
sell
Vivani Medical Inc.

Start price
Target price
Perf. (%)
€24.00
08.03.21
€15.00
08.03.22
32.50%
20.03.21

Good rating
Capable Management
Probably not worthwhile Investment
No Innovation
me8 
08.03.21 0%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€13.38
08.03.21
€15.00
13.62%
10.03.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
08.03.21 50%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€82.98
08.03.21
-
08.03.22
-72.98%
09.03.22

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Good rating
Standard Investments for future growth
FXX 
08.03.21 60%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€36.19
07.03.21
-
07.03.22
-62.14%
08.03.22

EBIT growth >5% per year expected
Capable Management
Could be worthwhile Investment >10% per year
Little innovation
OnkelSan 
07.03.21 0%
buy
X T L Biopharmaceuticals Ltd ADR

Start price
Target price
Perf. (%)
€2.80
06.03.21
-
06.03.22
-25.00%
07.03.22

Could be very worthwhile Investment >20% year
skyrockerZoe 
06.03.21 0%
buy
GSK plc

Start price
Target price
Perf. (%)
€14.42
04.03.21
€21.55
04.03.22
26.39%
05.03.22

Could be worthwhile Investment >10% per year
Very high dividend yield expected
Fair valuation
ROE higher than 10% per year
Gerardix 
04.03.21 70%
buy
Stratec SE

Start price
Target price
Perf. (%)
€116.60
03.03.21
€165.00
03.10.22
3.43%
06.04.22

Could be worthwhile Investment >10% per year
Covacoro 
03.03.21 70%
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€57.94
01.03.21
-
01.03.22
-2.93%
02.03.22

DirectorDealer 
01.03.21 50%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€130.34
27.02.21
-
27.02.22
37.81%
20.01.22

Innovative
Medium risks for its business
Top 10 in its market
Future proof or reliable business model
Troubadour 
27.02.21 50%
buy
Incyte Corp.

Start price
Target price
Perf. (%)
€64.63
25.02.21
€70.00
3.84%
08.03.21

Could be worthwhile Investment >10% per year
Traumtanz 
25.02.21 50%
sell
Incyte Corp.

Start price
Target price
Perf. (%)
€67.64
24.02.21
-
24.02.22
-12.39%
25.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
SpringheelJack 
24.02.21 50%
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€62.50
24.02.21
-
24.02.22
1.60%
30.03.21

Probably not worthwhile Investment
tinelchen 
24.02.21 0%
buy
Viracta Therapeutics Inc.

Start price
Target price
Perf. (%)
€15.09
23.02.21
-
23.02.22
18.33%
24.02.21

Innovative
Could be worthwhile Investment >10% per year
Good culture
No uniques
me8 
23.02.21 0%
buy
Astrazeneca ADR

Start price
Target price
Perf. (%)
€41.40
22.02.21
-
22.02.22
0.00%
10.03.21

Could be worthwhile Investment >10% per year
Medium risks for its business
Small cyclical dependencies
Gilbert 
22.02.21 50%
buy
Celsion Corp.

Start price
Target price
Perf. (%)
€35.70
22.02.21
€60.00
22.02.22
-37.40%
06.03.21

Could be worthwhile Investment >10% per year
Good culture
Leading role in innovation
high free float
me8 
22.02.21 0%
sell
Teleflex Inc.

Start price
Target price
Perf. (%)
€320.00
21.02.21
-
21.02.22
14.38%
23.04.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
CrazyEights 
21.02.21 50%
buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€8.98
21.02.21
€10.00
21.02.22
-54.90%
22.02.22

Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
kostojunior 
21.02.21 50%
buy
Vita 34 AG

Start price
Target price
Perf. (%)
€15.55
21.02.21
-
21.02.22
-25.08%
22.02.22

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
kostojunior 
21.02.21 0%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.22
21.02.21
-
21.02.22
-5.21%
06.03.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
21.02.21 0%
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€11.30
20.02.21
€6.80
20.02.22
-38.75%
10.07.21

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
20.02.21 50%
buy
iBio Inc.

Start price
Target price
Perf. (%)
€41.75
20.02.21
€27.50
20.02.22
-19.76%
06.05.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
geldnutzer 
20.02.21 60%
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€23.36
20.02.21
€26.40
20.02.22
-34.73%
06.05.21

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
geldnutzer 
20.02.21 50%